Influence of Polymers on the Physical and Chemical Stability of Spray-dried Amorphous Solid Dispersion: Dipyridamole Degradation Induced by Enteric Polymers

AAPS PharmSciTech. 2018 Aug;19(6):2620-2628. doi: 10.1208/s12249-018-1082-4. Epub 2018 Jun 18.

Abstract

Amorphous solid dispersions (ASDs) are inherently unstable because of high internal energy. Evaluating physical and chemical stability during the process and storage is essential. Numerous researches have demonstrated how polymers influence the drug precipitation and physical stability of ASDs, while the influence of polymers on the chemical stability of ASDs is often overlooked. Therefore, this study aimed to investigate the effect of polymers on the physical and chemical stability of spray-dried ASDs using dipyridamole (DP) as a model drug. Proper polymers were selected by assessing their abilities to inhibit drug recrystallization in supersaturated solutions. HPMC E5, Soluplus®, HPMCP-55, and HPMCAS-LP were shown to be effective stabilizers. The optimized formulations were further stored at a high temperature (60 °C) and high humidity (40 °C, 75% RH) for 2 months, and their physical and chemical stability was evaluated using polarizing optical microscopy, FTIR, HPLC, and mass spectrometry (MS). In general, crystallization was observed in all samples, which indicated the physical instability under stressed storage conditions. Also, it was noted that the polymers in ASDs rather than physical mixtures, induced a dramatic drug degradation after being exposed to a high temperature (HPMCP-55 > 80% and HPMCAS-LP > 50%) and high humidity (HPMCP-55 > 40% and HPMCAS-LP > 10%). The MS analysis further confirmed the degradation products, which might be generated from the reaction between dipyridamole and phthalic anhydride decomposed from HPMCP-55 and HPMCAS-LP. Overall, the exposure of ASDs to stressed conditions resulted in recrystallization and even the chemical degradation induced by polymers.

Keywords: degradation; dipyridamole (DP); physical aging; precipitation; solid dispersion (SD).

MeSH terms

  • Crystallization / methods
  • Dipyridamole / chemical synthesis*
  • Dipyridamole / pharmacokinetics*
  • Drug Compounding / methods
  • Drug Stability
  • Humidity
  • Methylcellulose / analogs & derivatives
  • Methylcellulose / chemical synthesis
  • Methylcellulose / pharmacokinetics
  • Phosphodiesterase Inhibitors / chemical synthesis
  • Phosphodiesterase Inhibitors / pharmacokinetics
  • Polyethylene Glycols / chemical synthesis
  • Polyethylene Glycols / pharmacokinetics
  • Polymers / chemical synthesis*
  • Polymers / pharmacokinetics*
  • Polyvinyls / chemical synthesis
  • Polyvinyls / pharmacokinetics
  • Solubility

Substances

  • Phosphodiesterase Inhibitors
  • Polymers
  • Polyvinyls
  • polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer
  • Polyethylene Glycols
  • Dipyridamole
  • hydroxypropylmethylcellulose acetate succinate
  • Methylcellulose